Detalhe da pesquisa
1.
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Cancer
; 127(9): 1417-1424, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351187
2.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Lancet
; 395(10241): 1907-1918, 2020 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473681
3.
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
J Am Acad Dermatol
; 79(6): 1081-1088, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025829
4.
Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing.
Lancet Oncol
; 21(3): 343-344, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950226
5.
Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targets.
Lancet Oncol
; 19(12): 1567-1568, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956641
6.
Efficacy and Safety of the MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series.
Onco Targets Ther
; 17: 267-280, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38567193
7.
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
Clin Ther
; 46(3): 228-238, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423866
8.
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
Cancer Res Commun
; 3(6): 1113-1117, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377610
9.
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation.
J Clin Oncol
; 41(25): 4097-4106, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099736
10.
Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354588
11.
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577503
12.
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies.
Clin Cancer Res
; 27(16): 4521-4530, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083236
13.
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations).
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34527850
14.
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy.
Clin Cancer Res
; 27(4): 1019-1028, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203644
15.
Oligometastatic Disease and Local Therapies: A Medical Oncology Perspective.
Cancer J
; 26(2): 144-148, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205539
16.
Optimizing Care for Patients With Adverse Events From Immunotherapeutics.
Cancer J
; 26(6): 537-542, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298725
17.
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting.
Clin Cancer Res
; 26(18): 4743-4747, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32571790
18.
Finding the Kool Mixx: how Brown & Williamson used music marketing to sell cigarettes.
Tob Control
; 15(5): 359-66, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16998169
19.
Could PD-L1 prove to be an effective therapeutic target for bladder cancer?
Immunotherapy
; 7(1): 1-2, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572474